Comparison of circulating tumor cells and AR-V7 as clinical biomarker in metastatic castration-resistant prostate cancer patients

Biomarker in metastatic castration resistant prostate cancer (mCRPC) treatment are rare. We aimed to compare the clinical value of circulating tumor cells (CTCs) and androgen receptor splice variant 7 (AR-V7) as biomarker in mCRPC patients undergoing androgen receptor-targeted agent (ARTA) treatment...

Descripción completa

Detalles Bibliográficos
Autores principales: Schlack, Katrin, Seitzer, Konstantin, Wüstmann, Neele, Humberg, Verena, Grundmann, Norbert, Steinestel, Julie, Tiedje, Dorothee, Rahbar, Kambiz, Krabbe, Laura-Maria, Bögemann, Martin, Schrader, Andres J., Bernemann, Christof
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9279395/
https://www.ncbi.nlm.nih.gov/pubmed/35831403
http://dx.doi.org/10.1038/s41598-022-16094-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9279395/
https://www.ncbi.nlm.nih.gov/pubmed/35831403
http://dx.doi.org/10.1038/s41598-022-16094-6

Ejemplares similares